The global Positron Emission Tomography (PET) market is projected to grow from $2.8 billion in 2024 to approximately $4.0 billion by 2034, at a CAGR of 3.7%. This increase is driven by the rising prevalence of chronic diseases, particularly cancer, and advancements in imaging technology, including hybrid systems integrating PET with CT and MRI. North America currently leads the market, accounting for 40.3% of revenue, supported by technological innovations and strong healthcare infrastructure. The Asia Pacific region is expected to experience the fastest growth due to increasing healthcare investments and demand for early diagnostic solutions. Advancements in radiotracers and AI integration are expanding PET's applications beyond oncology to neurology, cardiology, and infectious disease diagnostics, underscoring its importance in precision medicine and patient care.
Tue, 03 Jun 2025 07:22:18 GMT | Market.us Media